Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Dr. Myung (Brian) Chang is a board-certified prosthodontist and the Section Head of Maxillofacial Prosthodontics.
Before coming to Cleveland Clinic, Dr. Chang taught as a director of the Pre-doctoral Prosthodontics and participated in Faculty Group Practice at Harvard University School of Dental Medicine (2006-2012).
He was tenured and served as Dr. Merritt C. Pederson Endowed Chair Professor and a director of the Implant Program at University of Nebraska Medical Center(2000-2006).
Dr. Chang has been serving as a test constructor on the National Dental Board Examination and a reviewer board of peer review journals. He has made major contribution in research in the areas of maxillofacial prosthodontics, dental implant, materials and dental education.
Dr. Chang has received numerous awards during his academic career including the Claude B. Baker Faculty Award from the American Academy of Fixed Prosthodontics and the Distinguished Faculty Award from the Harvard School of Dental medicine. He has published scientific journal articles and lectured worldwide.
Prosthetic reconstruction for head and neck cancer patients, removable denture prosthesis, oral rehabilitation with dental implants, esthetic ceramic restorations
Residency – Northwestern University
Chicago, IL USA
Fellowship – Columbia University Medical Center
Maxillofacial Prosthodontics (1998)
New York, NY USA
University of Southern California (D.D.S.) (1993)
Los Angeles, CA USA
Seoul National University (D.D.S.) (1989)
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 5/4/2015, Dr. Chang has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.